Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development - Yahoo Finance

Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development  Yahoo Finance